To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SRSF11TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
727 representative clones for gene SRSF11 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC415520 trachea .a 1 to 560 2 to 565   tiling clone,   565/565
(100 %)
5 diff
(99.2 %id)
BM821368 stomach .a 2 to 480 1 to 471       471/471
(100 %)
5 diff
(99.0 %id)
BP209678 cerebellum .a 5 to 579 1 to 575       575/575
(100 %)
5 diff
(99.2 %id)
DA507112 brain .a 9 to 271 2 to 264   capped   263/263
(100 %)
0 diff
(100 %id)
DC295176 synovial membrane tissue from rheumatioidarthritis .a 26 to 583 1 to 558       558/558
(100 %)
0 diff
(100 %id)
DC321081 brain .a 29 to 521 1 to 493       493/493
(100 %)
0 diff
(100 %id)
DC332577 hippocampus .a 29 to 586 1 to 558       558/558
(100 %)
0 diff
(100 %id)
DC343117 thalamus .a 29 to 594 1 to 566       566/566
(100 %)
0 diff
(100 %id)
BP228890 brain .a 29 to 603 1 to 577       577/584
(98 %)
20 diff
(96.6 %id)
DC355504   .a 29 to 610 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DC366345   .a 29 to 535 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
DC400435 testis .a 29 to 559 1 to 534       534/534
(100 %)
3 diff
(99.5 %id)
DC406481 thymus .a 29 to 590 1 to 562       562/562
(100 %)
0 diff
(100 %id)
AU130539   .a 30 to 695 2 to 666   capped   665/665
(100 %)
9 diff
(98.7 %id)
DC403118 testis .a 30 to 583 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
DC389575 Spleen .a 35 to 622 1 to 588       588/589
(99 %)
2 diff
(99.7 %id)
DC422338 uterus .a 35 to 579 1 to 545       545/545
(100 %)
0 diff
(100 %id)
DC423575 uterus .a 35 to 584 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
DC322063 brain .a 38 to 574 1 to 537       537/537
(100 %)
1 diff
(99.9 %id)
BM272002 Pancreas, Purified pancreatic islet .a 41 to 541 1 to 501       501/501
(100 %)
3 diff
(99.5 %id)
CN425367 embryonic stem cells, DMSO-treated H9 cellline .a 44 to 378 1 to 335       335/335
(100 %)
0 diff
(100 %id)
BI225468 Burkitt lymphoma, lymph .a 44 to 665 1 to 622   available from MGC,   622/622
(100 %)
14 diff
(97.8 %id)
BC017359 Lymph, Burkitt lymphoma .a 45 to 1449 1 to 1405   tiling clone, available from MGC, AAA   1405/1405
(100 %)
0 diff
(100 %id)
CN425369 embryonic stem cells, DMSO-treated H9 cellline .a 51 to 347 1 to 297       297/297
(100 %)
0 diff
(100 %id)
CN425376 embryonic stem cells, DMSO-treated H9 cellline .a 52 to 525 1 to 474       474/474
(100 %)
0 diff
(100 %id)
DB449122 testis .a 60 to 478 1 to 418       418/418
(100 %)
2 diff
(99.6 %id)
DC375537 brain .a 60 to 641 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DC408201 thymus .a 60 to 634 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
BP366034 lung .a 67 to 653 1 to 587       587/587
(100 %)
0 diff
(100 %id)
DC378842   .a 73 to 637 1 to 565       565/565
(100 %)
0 diff
(100 %id)
DA982275 synovial membrane tissue from rheumatioidarthritis .a 95 to 674 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DC317151 amygdala .a 97 to 618 1 to 522       522/522
(100 %)
1 diff
(99.9 %id)
DA389414 thalamus .a 98 to 673 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA450561 tongue, tumor tissue .a 110 to 679 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DB449072 testis .a 111 to 544 1 to 434       434/434
(100 %)
1 diff
(99.8 %id)
DB486339 hypothalamus .a 111 to 534 1 to 424       424/425
(99 %)
2 diff
(99.6 %id)
DB107147 thymus .a 115 to 698 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DB473321 hippocampus .a 126 to 619 1 to 494       494/494
(100 %)
1 diff
(99.8 %id)
DB473852 hippocampus .a 126 to 612 1 to 487       487/487
(100 %)
5 diff
(99.0 %id)
DB453852 testis .a 127 to 615 1 to 489       489/489
(100 %)
2 diff
(99.6 %id)
DA518550 brain .a 128 to 695 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BQ777968 Pancreas, Purified pancreatic islet .a 129 to 653 1 to 525   fully sequenced,   525/525
(100 %)
4 diff
(99.3 %id)
CB108977 Liver .a 129 to 728 1 to 600       600/600
(100 %)
3 diff
(99.5 %id)
DC367823   .a 129 to 651 1 to 523       523/523
(100 %)
0 diff
(100 %id)
DC372676   .a 129 to 626 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
DC380427 placenta .a 129 to 626 1 to 498       498/498
(100 %)
0 diff
(100 %id)
DA904025   .a 129 to 697 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA910260   .a 129 to 705 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BI602021 brain, hypothalamus .a 132 to 877 1 to 743       743/884
(84 %)
17 diff
(98.1 %id)
AU131095   .a 132 to 825 2 to 693   capped Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 692/809
(85 %)
3 diff
(99.7 %id)
TI_45210001   .a 133 to 877 125 to 865   AAA   741/993
(74 %)
17 diff
(98.3 %id)
AU128917   .a 135 to 823 2 to 695   capped   694/694
(100 %)
8 diff
(98.9 %id)
CA407098 adipose .a 136 to 691 1 to 555       555/557
(99 %)
2 diff
(99.7 %id)
DB491530 hypothalamus .a 138 to 552 1 to 412       412/412
(100 %)
11 diff
(97.4 %id)
BU170698 eye, retinoblastoma .a 143 to 1011 9 to 879       871/885
(98 %)
13 diff
(98.6 %id)
BG472487 eye, retinoblastoma .a 148 to 841 1 to 689       689/689
(100 %)
9 diff
(98.7 %id)
BX439248 placenta .a 149 to 1059 1 to 907       907/930
(97 %)
6 diff
(99.4 %id)
BM787892 stomach .a 149 to 765 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
DA170308 amygdala .a 150 to 676 2 to 531   capped   530/530
(100 %)
3 diff
(99.5 %id)
DA710794   .a 150 to 702 2 to 554   capped   553/553
(100 %)
3 diff
(99.5 %id)
BC002784 Skin, melanotic melanoma. .a 151 to 1208 1 to 1058   available from MGC, AAA   1058/1058
(100 %)
0 diff
(100 %id)
BG168981 hypernephroma, cell line, Kidney .a 156 to 877 1 to 722       722/890
(81 %)
13 diff
(98.6 %id)
DA026778   .a 159 to 710 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA026793   .a 159 to 723 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BG896379 cartilage .a 159 to 439 86 to 366       281/298
(94 %)
6 diff
(98.0 %id)
DA506860 brain .a 159 to 708 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA705051   .a 162 to 704 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
AI244859 Kidney .a 165 to 434 1 to 270     Submitted on the opposite strand 270/270
(100 %)
3 diff
(98.9 %id)
BC009840 Placenta, choriocarcinoma .a 168 to 1008 1 to 841   available from MGC, AAA   841/841
(100 %)
0 diff
(100 %id)
BG575182 breast, mammary adenocarcinoma, cell line .a 168 to 916 1 to 748       748/748
(100 %)
3 diff
(99.6 %id)
BE386650 melanotic melanoma, skin .a 170 to 842 1 to 684   available from MGC,   684/688
(99 %)
30 diff
(95.7 %id)
CN425379 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 171 to 486 1 to 316       316/316
(100 %)
0 diff
(100 %id)
BI480860 Native Retinal Pigment Epithelium sheets, retina .a 177 to 337 12 to 172       161/179
(89 %)
1 diff
(99.5 %id)
CN425364 embryonic stem cells, cell lines H1, H7, andH9 .a 181 to 663 1 to 483       483/483
(100 %)
0 diff
(100 %id)
BE730696 choriocarcinoma, placenta .a 186 to 877 1 to 700   available from MGC,   702/735
(95 %)
18 diff
(97.6 %id)
CN425375 embryonic stem cells, DMSO-treated H9 cellline .a 215 to 952 1 to 738       738/738
(100 %)
0 diff
(100 %id)
BM793073 Ascites, stomach .a 245 to 686 1 to 442       442/442
(100 %)
1 diff
(99.8 %id)
BQ777665 Pancreas, Purified pancreatic islet .a 592 to 1006 414 to 1   fully sequenced,   414/414
(100 %)
10 diff
(97.6 %id)
AA558192 adrenal adenoma, adrenal gland .a 1156 to 1617 463 to 1       463/474
(97 %)
3 diff
(99.4 %id)
CX869063 embryonic stem .a 1203 to 2017 1 to 815   tiling clone, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 815/815
(100 %)
0 diff
(100 %id)
AI283371 ovary, tumor, 5 pooled (see description) .a 1293 to 1614 323 to 2       322/323
(99 %)
0 diff
(100 %id)
DB316145 brain .a 2017 to 2566 553 to 1   tiling clone,   553/553
(100 %)
4 diff
(99.3 %id)
AU152455   .a 2027 to 2566 537 to 1   tiling clone,   537/540
(99 %)
10 diff
(98.2 %id)
BX434165 placenta .a 2071 to 2913 864 to 6       859/877
(97 %)
0 diff
(100 %id)
CX868989 embryonic stem .a 2240 to 2956 743 to 27   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 717/717
(100 %)
1 diff
(99.9 %id)
AU151136   .a 2384 to 2972 592 to 1   tiling clone,   592/596
(99 %)
16 diff
(97.4 %id)
AU152920   .a 2468 to 2956 518 to 29   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 490/548
(89 %)
4 diff
(99.3 %id)
NM_004768.3   .b 1 to 2790 1 to 2790 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 2790/2790
(100 %)
0 diff
(100 %id)
BP871155 embryonal kidney .b 7 to 338 1 to 332   tiling clone,   332/332
(100 %)
0 diff
(100 %id)
DA335027 hippocampus .b 9 to 596 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA639119 Liver .b 9 to 508 2 to 502   capped   501/501
(100 %)
2 diff
(99.7 %id)
DA695954   .b 9 to 573 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB006133 breast, tumor tissue .b 9 to 538 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
DA547201   .b 10 to 568 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BP288925 lung .b 18 to 598 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
AU128045   .b 19 to 663 2 to 646   capped   645/728
(88 %)
3 diff
(99.6 %id)
TI_159723011   .b 22 to 847 896 to 78   tiling clone, AAA   819/996
(82 %)
14 diff
(98.6 %id)
TI_154154755   .b 35 to 664 80 to 709       630/637
(98 %)
2 diff
(99.7 %id)
BG944186 blood .b 36 to 538 1 to 503       503/503
(100 %)
2 diff
(99.7 %id)
DB030062 testis .b 38 to 606 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA042244 bladder .b 39 to 598 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA715809   .b 39 to 575 2 to 542   capped   541/541
(100 %)
4 diff
(99.3 %id)
DA762097 tongue .b 44 to 553 2 to 511   capped   510/510
(100 %)
0 diff
(100 %id)
DA847135 placenta .b 44 to 601 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DB266099 uterus .b 44 to 637 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DA516446 brain .b 47 to 581 2 to 538   capped   537/537
(100 %)
2 diff
(99.7 %id)
BP336680 coronary artery .b 47 to 657 1 to 611       611/611
(100 %)
1 diff
(99.9 %id)
CN338096 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 52 to 321 1 to 270       270/270
(100 %)
0 diff
(100 %id)
BU930870 ovary, teratocarcinoma, cell line .b 53 to 840 1 to 788   AAA   788/792
(99 %)
1 diff
(99.9 %id)
CN338095 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 59 to 628 1 to 570       570/570
(100 %)
3 diff
(99.5 %id)
DA578621   .b 59 to 624 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
AA102179 Pancreas .b 59 to 440 1 to 384       384/384
(100 %)
8 diff
(98.0 %id)
AU131918   .b 74 to 893 2 to 821   capped   820/831
(98 %)
5 diff
(99.4 %id)
DB017492 esophageal, tumor tissue .b 74 to 604 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
BP319017 pericardium .b 94 to 675 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
TI_154159648   .b 97 to 716 95 to 713       619/635
(97 %)
11 diff
(98.3 %id)
AW503704 lymph .b 99 to 616 10 to 526       517/526
(98 %)
6 diff
(98.9 %id)
CX760826 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 101 to 846 12 to 754     Submitted on the opposite strand 743/754
(98 %)
19 diff
(97.5 %id)
TI_1948209459   .b 124 to 843 124 to 856       733/1181
(62 %)
26 diff
(97.8 %id)
TI_1948209615   .b 124 to 850 125 to 853       729/1235
(59 %)
21 diff
(98.3 %id)
TI_1948209771   .b 124 to 808 126 to 813       688/1232
(55 %)
11 diff
(99.2 %id)
TI_1948209929   .b 124 to 834 125 to 838       714/1092
(65 %)
18 diff
(98.4 %id)
AA074522 Pancreas .b 536 to 664 137 to 5       134/137
(97 %)
1 diff
(99.3 %id)
CR614713 fetal liver .b 632 to 2752 1 to 2121   tiling clone,   2121/2121
(100 %)
0 diff
(100 %id)
CX165511 human embryonic stem cells differentiated toan early endodermal cell type .b 817 to 1691 1 to 875       875/875
(100 %)
1 diff
(99.9 %id)
BQ774036 Bone, Human Chondrosarcoma Cell Line .b 829 to 1434 50 to 655     Submitted on the opposite strand 606/639
(94 %)
1 diff
(99.9 %id)
CA429339 Cell Line, Chondrosarcoma .b 829 to 1432 50 to 653     Submitted on the opposite strand 604/637
(94 %)
1 diff
(99.9 %id)
TI_1948209616   .b 842 to 1578 861 to 125       737/1296
(56 %)
16 diff
(98.8 %id)
TI_1948209460   .b 846 to 1578 851 to 121       731/1243
(58 %)
4 diff
(99.7 %id)
AA196350 muscle, skeletal muscle .b 850 to 1436 584 to 1     Submitted on the opposite strand 584/593
(98 %)
8 diff
(98.7 %id)
TI_1948209930   .b 852 to 1578 853 to 125       729/1332
(54 %)
13 diff
(99.1 %id)
CR991499 T-Lymphocytes .b 894 to 1633 1 to 742       742/742
(100 %)
2 diff
(99.8 %id)
TI_1948209772   .b 899 to 1578 802 to 120       683/1344
(50 %)
27 diff
(98.0 %id)
CN419350 embryonic stem cells, cell lines H1, H7, andH9 .b 912 to 1504 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
BE938083 testis_normal .b 956 to 1572 615 to 1       615/619
(99 %)
6 diff
(99.1 %id)
DA073317 cerebellum .b 961 to 1502 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
CX787139 human embryonic stem cells .b 982 to 1821 1 to 840       840/840
(100 %)
0 diff
(100 %id)
CA397581 eye, RPE/choroid .b 1028 to 1518 1 to 491       491/491
(100 %)
2 diff
(99.6 %id)
T08663   .b 1028 to 1394 1 to 367       367/367
(100 %)
0 diff
(100 %id)
CN419334 embryonic stem cells, DMSO-treated H9 cellline .b 1056 to 1699 1 to 644       644/644
(100 %)
0 diff
(100 %id)
BM837585 Ascites, stomach .b 1064 to 1726 1 to 663       663/663
(100 %)
0 diff
(100 %id)
DA606835   .b 1072 to 1616 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
CN419343 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1073 to 1830 1 to 758       758/758
(100 %)
1 diff
(99.9 %id)
BP263351 small intestine .b 1091 to 1662 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
AA076158   .b 1096 to 1424 1 to 329   fully sequenced,   329/329
(100 %)
6 diff
(98.2 %id)
BG913749 anaplastic oligodendroglioma with 1p/19qloss, brain .b 1142 to 1725 1 to 603   AAA   569/955
(59 %)
14 diff
(98.6 %id)
CB159745 Liver .b 1155 to 1664 1 to 510       510/510
(100 %)
1 diff
(99.9 %id)
AA165077   .b 1160 to 1668 1 to 509       509/509
(100 %)
4 diff
(99.3 %id)
EB385458 eye, optic nerve .b 1167 to 1975 1 to 808       808/808
(100 %)
1 diff
(99.9 %id)
AW368709 head_neck .b 1222 to 1393 1 to 172       172/172
(100 %)
0 diff
(100 %id)
AI979172 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 1231 to 1435 205 to 1       205/205
(100 %)
0 diff
(100 %id)
TI_149278802   .b 1241 to 1711 143 to 610     Submitted on the opposite strand 468/785
(59 %)
7 diff
(99.2 %id)
CB136235 Liver .b 1248 to 1810 1 to 563       563/563
(100 %)
0 diff
(100 %id)
CN419338 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1261 to 1946 1 to 686       686/686
(100 %)
0 diff
(100 %id)
BM689762 eye, Retina Foveal and Macular .b 1292 to 1748 1 to 457       457/457
(100 %)
2 diff
(99.6 %id)
BQ441591 testis .b 1294 to 2045 1 to 760       760/827
(91 %)
14 diff
(98.4 %id)
BM721429 eye, fetal eye .b 1300 to 1936 1 to 635     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 635/635
(100 %)
2 diff
(99.7 %id)
AA076076   .b 1316 to 1435 121 to 1   fully sequenced,   121/121
(100 %)
0 diff
(100 %id)
BU608454 Human Lung Epithelial cells, lung .b 1325 to 2037 731 to 19   AAA   713/713
(100 %)
0 diff
(100 %id)
CB132307 Liver .b 1330 to 1941 1 to 612       612/612
(100 %)
0 diff
(100 %id)
AA403085   .b 1369 to 1430 1 to 62       62/62
(100 %)
6 diff
(90.4 %id)
DA648688   .b 1370 to 1914 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
TI_154132606   .b 1374 to 2029 757 to 102   AAA   656/862
(76 %)
6 diff
(99.4 %id)
FN135181 breast carcinoma .b 1379 to 1504 126 to 1     Submitted on the opposite strand 126/128
(98 %)
5 diff
(96.1 %id)
BU740495 eye, fetal eye .b 2161 to 2774 632 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 614/614
(100 %)
2 diff
(99.7 %id)
AU150374   .b 2216 to 2774 560 to 1       560/560
(100 %)
13 diff
(97.7 %id)
AA411816   .b 2232 to 2775 548 to 5   tiling clone,   544/548
(99 %)
0 diff
(100 %id)
AU153573   .b 2285 to 2766 496 to 9       488/572
(85 %)
0 diff
(100 %id)
AA164680   .b 2329 to 2773 445 to 1       445/446
(99 %)
0 diff
(100 %id)
M74002 Liver .c 1 to 2726 6 to 2736 V420Q T421V R422T D423R Y424D ... tiling clone,   2736/2736
(100 %)
6 diff
(99.8 %id)
DA718199   .d 1 to 548 2 to 549   tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
DR155979 human embryonic stem cells differentiated toan early endodermal cell type .d 23 to 716 1 to 694       694/694
(100 %)
0 diff
(100 %id)
AU125463   .d 28 to 870 2 to 847   tiling clone, capped   846/853
(99 %)
8 diff
(99.1 %id)
AU131222   .d 28 to 853 2 to 828   tiling clone, capped   827/834
(99 %)
6 diff
(99.3 %id)
AU149121   .d 1744 to 2326 585 to 1   tiling clone,   585/592
(98 %)
8 diff
(98.7 %id)
AU153003   .d 2197 to 2716 521 to 1   tiling clone,   521/551
(94 %)
13 diff
(97.7 %id)
DA675281   .e 1 to 590 2 to 591   tiling clone, capped   590/590
(100 %)
0 diff
(100 %id)
BX641004 human fetal kidney .e 531 to 3768 1 to 3241   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 3241/3241
(100 %)
11 diff
(99.7 %id)
BG621700 placenta .e 1780 to 2623 1 to 857       857/868
(98 %)
35 diff
(96.0 %id)
N78396 multiple sclerosis lesions .e 1852 to 2300 1 to 453   fully sequenced,   453/453
(100 %)
6 diff
(98.7 %id)
DA531024 brain .e 1855 to 2461 2 to 608   capped   607/607
(100 %)
0 diff
(100 %id)
DB523820 testis .e 1874 to 2330 1 to 457     Submitted on the opposite strand 457/457
(100 %)
0 diff
(100 %id)
AI368172 adenocarcinoma, colon .e 1875 to 2331 457 to 1       457/457
(100 %)
0 diff
(100 %id)
AI339897 adenocarcinoma, colon .e 1881 to 2331 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AI628713 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .e 1882 to 2332 451 to 1       451/451
(100 %)
0 diff
(100 %id)
BF794996 lymph, lymphoma, cell line .e 1887 to 2720 1 to 835       835/852
(98 %)
23 diff
(97.4 %id)
TI_149300454   .e 1892 to 2721 906 to 83   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 824/963
(85 %)
18 diff
(98.2 %id)
DB517631 testis .e 1894 to 2331 1 to 438     Submitted on the opposite strand 438/438
(100 %)
0 diff
(100 %id)
AI354505 follicular lymphoma, lymph node .e 1895 to 2328 434 to 1       434/434
(100 %)
0 diff
(100 %id)
AI074679 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1913 to 2326 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AW152161 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1916 to 2333 418 to 1       418/418
(100 %)
0 diff
(100 %id)
TI_154115322   .e 1934 to 2721 865 to 81   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 785/953
(82 %)
10 diff
(99.0 %id)
AI251439 brain, tumor, 5 pooled (see description) .e 1941 to 2331 391 to 1       391/391
(100 %)
0 diff
(100 %id)
CD655119 Embryonic Stem cells .e 1944 to 2721 818 to 47   AAA Submitted on the opposite strand 772/808
(95 %)
20 diff
(97.6 %id)
TI_154128875   .e 1944 to 2715 870 to 101   AAA   770/1002
(76 %)
0 diff
(100 %id)
BE672710 carcinoid, lung .e 1952 to 2334 383 to 1       383/383
(100 %)
0 diff
(100 %id)
AI351868 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1965 to 2326 362 to 1       362/362
(100 %)
0 diff
(100 %id)
BQ429326 testis .e 2004 to 2721 1 to 735       735/823
(89 %)
27 diff
(96.8 %id)
AI864927 lymph node, lymphoma, follicular mixed small and largecell .e 2013 to 2331 335 to 17   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 319/319
(100 %)
0 diff
(100 %id)
BQ225795 melanotic melanoma, skin .e 2018 to 2719 1 to 705       705/917
(76 %)
7 diff
(99.3 %id)
CA417788 Chondrosarcoma Cell line .e 2035 to 2715 705 to 25   AAA   681/687
(99 %)
0 diff
(100 %id)
BM315085 Pancreas, Purified pancreatic islet .e 2043 to 2569 1 to 527       527/527
(100 %)
0 diff
(100 %id)
BM976518 lung, Primary Lung Cystic Fibrosis EpithelialCells .e 2055 to 2721 685 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 667/667
(100 %)
3 diff
(99.6 %id)
CK825090 Pancreas, Purified pancreatic islet .e 2067 to 2644 1 to 578     Submitted on the opposite strand 578/578
(100 %)
0 diff
(100 %id)
CA449074 Chondrosarcoma, Left Pubic Bone .e 2091 to 2721 649 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 631/631
(100 %)
1 diff
(99.9 %id)
BE219025 carcinoid, lung .e 2109 to 2492 1 to 384     Submitted on the opposite strand 384/384
(100 %)
0 diff
(100 %id)
AI446378 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 2136 to 2331 196 to 1       196/196
(100 %)
0 diff
(100 %id)
CA314245 Human Lung Epithelial cells, lung .e 2138 to 2737 617 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 599/599
(100 %)
2 diff
(99.7 %id)
BM971164 lung, Primary Lung Epithelial Cells .e 2162 to 2737 594 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 576/580
(99 %)
2 diff
(99.7 %id)
AL044073 testis .e 2163 to 2722 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BE878248 large cell carcinoma, undifferentiated, lung .e 2172 to 2918 1 to 748       748/861
(86 %)
28 diff
(96.8 %id)
AI146826 heart .e 2193 to 2721 529 to 1       529/529
(100 %)
0 diff
(100 %id)
AI743096 pooled .e 2193 to 2741 554 to 6       549/554
(99 %)
0 diff
(100 %id)
AI401804 Prostate .e 2194 to 2721 528 to 1       528/528
(100 %)
0 diff
(100 %id)
H43729 breast .e 2201 to 2531 1 to 343   fully sequenced,   343/343
(100 %)
3 diff
(99.2 %id)
AW006338 colon .e 2214 to 2721 508 to 1       508/508
(100 %)
0 diff
(100 %id)
TI_151697491   .e 2216 to 2721 599 to 94   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 506/506
(100 %)
0 diff
(100 %id)
AI081534 Kidney .e 2228 to 2741 515 to 2       514/515
(99 %)
0 diff
(100 %id)
AW572522 adenocarcinoma, Pancreas .e 2228 to 2721 494 to 1       494/494
(100 %)
0 diff
(100 %id)
BF444921 carcinoid, lung .e 2229 to 2740 512 to 1       512/512
(100 %)
0 diff
(100 %id)
AI379306 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2236 to 2737 502 to 1       502/502
(100 %)
0 diff
(100 %id)
AI383974 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2238 to 2721 484 to 1       484/484
(100 %)
0 diff
(100 %id)
AW874312 tumor, uterus .e 2253 to 2721 469 to 1       469/469
(100 %)
0 diff
(100 %id)
BE219407 carcinoid, lung .e 2262 to 2721 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AU120053 whole embryo, mainly head .e 2265 to 3071 2 to 806   tiling clone, capped   805/808
(99 %)
7 diff
(99.2 %id)
BE669816 carcinoid, lung .e 2267 to 2724 1 to 458     Submitted on the opposite strand 458/458
(100 %)
0 diff
(100 %id)
N62625 multiple sclerosis lesions .e 2272 to 2721 451 to 1   fully sequenced,   451/451
(100 %)
1 diff
(99.8 %id)
BF110325 carcinoid, lung .e 2272 to 2679 1 to 408     Submitted on the opposite strand 408/408
(100 %)
0 diff
(100 %id)
AI671982 Kidney .e 2291 to 2741 452 to 2       451/452
(99 %)
0 diff
(100 %id)
AA670045 bone marrow stroma .e 2298 to 2722 425 to 1       425/425
(100 %)
0 diff
(100 %id)
AA937962 germinal center B cell .e 2299 to 2737 449 to 11   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 439/439
(100 %)
1 diff
(99.8 %id)
AA523594 lung, lung tumor .e 2300 to 2720 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AI168542 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 2330 to 2721 392 to 1       392/392
(100 %)
0 diff
(100 %id)
AA837285 germinal center B cell .e 2333 to 2721 409 to 21   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 389/389
(100 %)
0 diff
(100 %id)
AI564260 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 2359 to 2741 388 to 6       383/388
(98 %)
0 diff
(100 %id)
AA682984 schizophrenic brain S-11 frontal lobe .e 2371 to 2736 366 to 1       366/366
(100 %)
0 diff
(100 %id)
BF965915 Bone, osteosarcoma, cell line .e 2371 to 2721 1 to 351   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 351/351
(100 %)
0 diff
(100 %id)
AW084230 esophagus, squamous cell carcinoma .e 2385 to 2737 374 to 22   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 353/353
(100 %)
0 diff
(100 %id)
AA669977 bone marrow stroma .e 2386 to 2720 335 to 1       335/335
(100 %)
0 diff
(100 %id)
AI094540 pooled .e 2412 to 2721 310 to 1       310/310
(100 %)
0 diff
(100 %id)
BG535332 lung .e 2412 to 3007 1 to 609       609/742
(82 %)
25 diff
(96.7 %id)
H28216 breast .e 2419 to 2705 287 to 1       287/287
(100 %)
0 diff
(100 %id)
BF693423 muscle (skeletal) .e 2429 to 3180 1 to 732       732/773
(94 %)
43 diff
(94.5 %id)
BF576260 muscle (skeletal) .e 2429 to 3115 1 to 684       684/870
(78 %)
33 diff
(96.3 %id)
BY999066   .e 2494 to 2739 1 to 246     Submitted on the opposite strand 246/247
(99 %)
4 diff
(98.4 %id)
H43673 breast .e 2501 to 2740 243 to 1   fully sequenced,   243/243
(100 %)
2 diff
(99.2 %id)
BF698096 brain, primitive neuroectoderm .e 2501 to 3220 1 to 714       714/736
(97 %)
21 diff
(97.2 %id)
CR599215 thymus .e 2541 to 3750 1 to 1210   tiling clone,   1210/1210
(100 %)
0 diff
(100 %id)
BX415309 thymus .e 2541 to 3289 1 to 751   fully sequenced,   751/751
(100 %)
0 diff
(100 %id)
BG483262 lung .e 2547 to 3203 1 to 662       662/717
(92 %)
12 diff
(98.4 %id)
CA337837 1st pharyngeal arch (pooled) .e 2562 to 2721 1 to 160   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 160/160
(100 %)
0 diff
(100 %id)
BF681275 Prostate .e 2564 to 3205 1 to 628       628/834
(75 %)
20 diff
(97.7 %id)
BQ022377 placenta .e 2615 to 2721 124 to 18   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 107/107
(100 %)
0 diff
(100 %id)
BE568681 bladder, carcinoma, cell line .e 2634 to 3204 1 to 577       577/650
(88 %)
23 diff
(96.5 %id)
N47282 multiple sclerosis lesions .e 2642 to 2901 1 to 261       261/263
(99 %)
5 diff
(98.1 %id)
BF185220 bone marrow, from chronic myelogenous leukemia .e 2651 to 3340 1 to 676       676/849
(79 %)
31 diff
(96.4 %id)
BG494115 lung, mucoepidermoid carcinoma .e 2662 to 3423 1 to 759       759/762
(99 %)
10 diff
(98.7 %id)
BG925486 cartilage .e 2676 to 3309 86 to 724       639/656
(97 %)
6 diff
(99.1 %id)
BF666387 brain, primitive neuroectoderm .e 2701 to 3406 1 to 692       692/811
(85 %)
28 diff
(96.6 %id)
BF696995 brain, primitive neuroectoderm .e 2701 to 3402 1 to 702       702/809
(86 %)
34 diff
(95.8 %id)
BF680379 Prostate .e 2703 to 3426 1 to 712       712/865
(82 %)
30 diff
(96.6 %id)
BU568983 testis .e 2711 to 3349 1 to 644       644/810
(79 %)
8 diff
(99.1 %id)
BF132511 lung, mucoepidermoid carcinoma .e 2720 to 3206 1 to 481       481/798
(60 %)
11 diff
(98.7 %id)
BI919079 brain .e 2753 to 3425 1 to 673       673/673
(100 %)
8 diff
(98.9 %id)
TI_57241899   .e 2753 to 3425 1 to 673       673/673
(100 %)
8 diff
(98.9 %id)
BF969988 adrenal cortex carcinoma, cell line, adrenal gland .e 2765 to 3576 1 to 814       814/907
(89 %)
37 diff
(96.0 %id)
BF027904 bladder, carcinoma, cell line .e 2806 to 3340 1 to 530       530/688
(77 %)
17 diff
(97.6 %id)
CN294419 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 2930 to 3512 1 to 586       586/586
(100 %)
8 diff
(98.7 %id)
FN064116 breast carcinoma .e 2948 to 3065 119 to 1     Submitted on the opposite strand 119/119
(100 %)
1 diff
(99.2 %id)
FN093042 breast carcinoma .e 2970 to 3078 110 to 1     Submitted on the opposite strand 110/110
(100 %)
1 diff
(99.1 %id)
DA040114 bladder .e 3064 to 3440 2 to 380   fully sequenced, capped   379/379
(100 %)
1 diff
(99.8 %id)
TI_149294644   .e 3090 to 3770 55 to 737     Submitted on the opposite strand 683/1018
(67 %)
4 diff
(99.7 %id)
CB854732 lung .e 3090 to 3757 18 to 687     Submitted on the opposite strand 670/687
(97 %)
6 diff
(99.2 %id)
BP417098 small intestine .e 3114 to 3620 1 to 509     Submitted on the opposite strand 509/509
(100 %)
1 diff
(99.9 %id)
R24606 placenta .e 3176 to 3498 16 to 349   fully sequenced,   334/349
(95 %)
6 diff
(98.3 %id)
BP432067   .e 3184 to 3442 1 to 261       261/261
(100 %)
1 diff
(99.7 %id)
AA837757 ovary .e 3191 to 3567 1 to 379       379/379
(100 %)
6 diff
(98.5 %id)
N99675 melanocyte .e 3195 to 3649 1 to 471       471/473
(99 %)
19 diff
(96.0 %id)
CB853085 Human Lung Epithelial cells, lung .e 3196 to 3765 1 to 572     Submitted on the opposite strand 572/581
(98 %)
5 diff
(99.2 %id)
TI_159722362   .e 3200 to 3765 53 to 620     Submitted on the opposite strand 568/1123
(50 %)
2 diff
(99.9 %id)
AU146237 whole embryo, mainly head .e 3212 to 3768 564 to 1       564/565
(99 %)
18 diff
(96.9 %id)
R23662 placenta .e 3223 to 3517 1 to 302   fully sequenced,   302/302
(100 %)
8 diff
(97.4 %id)
AA258705 germinal center B cell .e 3224 to 3599 1 to 378       378/378
(100 %)
1 diff
(99.8 %id)
AA233008 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 3226 to 3446 1 to 223       223/223
(100 %)
1 diff
(99.6 %id)
BX456997 thymus .e 3259 to 3750 494 to 1   fully sequenced,   494/494
(100 %)
2 diff
(99.6 %id)
BF062949 colon, colon tumor, RER+ .e 3263 to 3770 512 to 3       510/512
(99 %)
0 diff
(100 %id)
TI_157610650   .e 3264 to 3768 648 to 143   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 506/953
(53 %)
44 diff
(95.4 %id)
AA530877 normal prostate, Prostate .e 3273 to 3769 498 to 1       498/501
(99 %)
5 diff
(99.1 %id)
AI002238 carcinoid, lung .e 3275 to 3768 501 to 15   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 487/591
(82 %)
19 diff
(96.8 %id)
FN050935 breast carcinoma .e 3280 to 3412 1 to 137       137/137
(100 %)
3 diff
(97.9 %id)
FN132187 breast carcinoma .e 3282 to 3414 132 to 1     Submitted on the opposite strand 132/132
(100 %)
6 diff
(95.5 %id)
AI470004 pooled .e 3291 to 3773 487 to 3   tiling clone,   485/487
(99 %)
0 diff
(100 %id)
AI685019 Kidney .e 3306 to 3737 443 to 10       434/454
(95 %)
0 diff
(100 %id)
AI075888   .e 3315 to 3772 458 to 1       458/458
(100 %)
0 diff
(100 %id)
N48600 multiple sclerosis lesions .e 3348 to 3768 428 to 1       428/429
(99 %)
8 diff
(98.2 %id)
BP386822 pancreatic islet .e 3356 to 3743 1 to 389     Submitted on the opposite strand 389/389
(100 %)
1 diff
(99.8 %id)
AI566072 Kidney .e 3384 to 3773 392 to 3       390/392
(99 %)
0 diff
(100 %id)
AI620512 Prostate .e 3396 to 3768 392 to 20   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 373/373
(100 %)
1 diff
(99.8 %id)
FN071270 breast carcinoma .e 3401 to 3513 118 to 1     Submitted on the opposite strand 118/121
(97 %)
5 diff
(95.9 %id)
FN104877 breast carcinoma .e 3402 to 3509 114 to 1     Submitted on the opposite strand 114/123
(92 %)
6 diff
(95.2 %id)
DB295947 bladder .e 3410 to 3766 360 to 1   fully sequenced,   360/360
(100 %)
1 diff
(99.8 %id)
FN106719 breast carcinoma .e 3431 to 3536 104 to 5     Submitted on the opposite strand 100/104
(96 %)
0 diff
(100 %id)
AA491569 Ewing's sarcoma .e 3434 to 3768 345 to 11   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 335/336
(99 %)
0 diff
(100 %id)
R24506 placenta .e 3481 to 3773 307 to 4   fully sequenced,   304/307
(99 %)
0 diff
(100 %id)
R26575 placenta .e 3487 to 3765 288 to 1   fully sequenced,   288/288
(100 %)
4 diff
(98.7 %id)
FN049088 breast carcinoma .e 3494 to 3600 1 to 107       107/107
(100 %)
0 diff
(100 %id)
AI613287 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .e 3500 to 3767 270 to 3       268/270
(99 %)
0 diff
(100 %id)
AA233375 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 3510 to 3768 259 to 1       259/259
(100 %)
0 diff
(100 %id)
AI648429 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .e 3528 to 3766 270 to 31   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 240/240
(100 %)
13 diff
(94.6 %id)
T10714   .e 3555 to 3773 221 to 1       221/314
(70 %)
12 diff
(96.2 %id)
BP284706 bone marrow .f 1 to 601 1 to 603   tiling clone,   603/603
(100 %)
2 diff
(99.7 %id)
BC022815 Skin, melanotic melanoma. .f 13 to 856 1 to 844   available from MGC, AAA   844/844
(100 %)
0 diff
(100 %id)
NM_001190987.1   .f 13 to 2796 1 to 2784 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 2784/2784
(100 %)
0 diff
(100 %id)
TI_44345794   .f 20 to 776 85 to 841       757/841
(90 %)
6 diff
(99.3 %id)
DB180255 kidney, tumor tissue .f 20 to 559 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
BG706844 brain, hypothalamus .f 22 to 817 1 to 799       799/799
(100 %)
12 diff
(98.5 %id)
BI670318 brain, hypothalamus .f 22 to 776 1 to 755       755/755
(100 %)
6 diff
(99.3 %id)
DB487157 hypothalamus .f 30 to 468 1 to 439       439/439
(100 %)
0 diff
(100 %id)
DA529078 brain .f 31 to 640 2 to 611   capped   610/610
(100 %)
0 diff
(100 %id)
BC032727 Uterus, leiomyosarcoma .f 37 to 856 12 to 831   available from MGC, AAA   820/820
(100 %)
0 diff
(100 %id)
BG677877 skin, squamous cell carcinoma .f 38 to 849 1 to 818       818/934
(87 %)
22 diff
(97.7 %id)
DN991833 brain, whole brain .f 38 to 795 1 to 757       757/800
(94 %)
5 diff
(99.4 %id)
BI463866 testis .f 51 to 723 1 to 673       673/673
(100 %)
4 diff
(99.5 %id)
BM454998 leiomyosarcoma, uterus .f 53 to 932 42 to 922       881/996
(88 %)
18 diff
(98.2 %id)
BM463716 leiomyosarcoma, uterus .f 54 to 876 29 to 856       828/1076
(76 %)
14 diff
(98.7 %id)
BC040436 Uterus, leiomyosarcoma .f 55 to 2390 1 to 2336 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 2336/2336
(100 %)
0 diff
(100 %id)
BP244566 Kidney .f 55 to 636 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA553504   .f 56 to 624 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA689770   .f 56 to 594 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA874662 Prostate .f 56 to 621 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA746729   .f 59 to 628 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA285279 corpus callosum .f 60 to 613 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA296623 hippocampus .f 60 to 639 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BM792855 Ascites, stomach .f 68 to 733 1 to 666       666/666
(100 %)
0 diff
(100 %id)
DB123164 thymus .f 68 to 605 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
AL045062 testis .f 70 to 395 1 to 326       326/326
(100 %)
0 diff
(100 %id)
AW402452 lymph .f 70 to 525 8 to 463       456/463
(98 %)
6 diff
(98.8 %id)
DA688395   .f 88 to 638 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
CN425372 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 107 to 682 1 to 576       576/576
(100 %)
0 diff
(100 %id)
CR992085 T-Lymphocytes .f 116 to 659 1 to 544       544/545
(99 %)
1 diff
(99.9 %id)
CN425366 embryonic stem cells, DMSO-treated H9 cellline .f 117 to 648 1 to 532       532/532
(100 %)
0 diff
(100 %id)
BE887320 leiomyosarcoma, uterus .f 119 to 766 1 to 648       648/648
(100 %)
0 diff
(100 %id)
EL734396 mixed .f 134 to 781 1 to 645       645/645
(100 %)
3 diff
(99.6 %id)
CN425363 embryonic stem cells, cell lines H1, H7, andH9 .f 144 to 789 1 to 646       646/646
(100 %)
0 diff
(100 %id)
CN425370 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 150 to 787 1 to 638       638/638
(100 %)
0 diff
(100 %id)
DR156930 human embryonic stem cells differentiated toan early endodermal cell type .f 157 to 988 1 to 832       832/832
(100 %)
0 diff
(100 %id)
BI600298 brain, hypothalamus .f 163 to 915 1 to 755       755/759
(99 %)
10 diff
(98.7 %id)
TI_45215288   .f 164 to 915 84 to 837       754/841
(89 %)
13 diff
(98.5 %id)
CA944821 Human Lung Epithelial cells, lung .f 217 to 856 655 to 16   AAA   640/640
(100 %)
3 diff
(99.6 %id)
DA706350   .f 299 to 874 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
CN425377 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .f 317 to 447 1 to 131       131/131
(100 %)
0 diff
(100 %id)
CA313349 Human Lung Epithelial cells, lung .f 351 to 1069 736 to 19   AAA   720/718
(100 %)
4 diff
(99.5 %id)
BU628868 cell lines, Chondrosarcoma .f 351 to 1069 737 to 19   AAA   719/719
(100 %)
0 diff
(100 %id)
BG117113 adenocarcinoma, cell line, Liver .f 375 to 1052 1 to 673       673/979
(68 %)
11 diff
(98.9 %id)
AW069570 bone marrow stroma .f 469 to 949 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
AI701320 adenocarcinoma, Pancreas .f 473 to 677 205 to 1       205/205
(100 %)
0 diff
(100 %id)
AU128230   .f 509 to 1051 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
BM803714 leiomyosarcoma, uterus .f 527 to 1249 14 to 743       730/1104
(66 %)
22 diff
(98.1 %id)
BQ440460 leiomyosarcoma, uterus .f 534 to 1423 1 to 900       900/902
(99 %)
23 diff
(97.5 %id)
AI560814 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 564 to 1282 719 to 1       719/720
(99 %)
11 diff
(98.5 %id)
AA333395 Embryo, 8 weeks .f 570 to 839 1 to 270       270/270
(100 %)
0 diff
(100 %id)
TI_154046975   .f 573 to 1249 778 to 106   AAA   673/900
(74 %)
10 diff
(98.9 %id)
CB130164 Liver .f 604 to 1246 1 to 641       641/641
(100 %)
3 diff
(99.6 %id)
BG617323 Liver .f 608 to 1279 1 to 676       676/922
(73 %)
8 diff
(99.2 %id)
CN419333 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 638 to 1353 733 to 18     Submitted on the opposite strand 716/733
(97 %)
0 diff
(100 %id)
BG284598 adenocarcinoma, cell line, Prostate .f 661 to 1424 1 to 761   AAA   761/770
(98 %)
15 diff
(98.1 %id)
BM144239 leukopheresis .f 682 to 839 191 to 34   AAA   158/160
(98 %)
3 diff
(98.2 %id)
AW150349 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .f 695 to 1277 583 to 1       583/583
(100 %)
0 diff
(100 %id)
BG743166 skin .f 713 to 1452 1 to 740       740/740
(100 %)
3 diff
(99.6 %id)
BQ890739 sciatic nerve .f 751 to 1623 1 to 881       881/906
(97 %)
58 diff
(93.6 %id)
CD687770 normal nasopharynx .f 754 to 1105 1 to 352       352/352
(100 %)
0 diff
(100 %id)
CA423820 cell lines, Chondrosarcoma .f 781 to 1450 674 to 2   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 673/674
(99 %)
2 diff
(99.8 %id)
AL043760 testis .f 782 to 1374 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BP293104 lung .f 806 to 1387 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BG502724 embryonal carcinoma, testis .f 811 to 1478 1 to 670       670/670
(100 %)
7 diff
(99.0 %id)
BF984926 duodenal adenocarcinoma, cell line, small intestine .f 853 to 1617 1 to 769       769/916
(83 %)
22 diff
(97.6 %id)
BM856385 stomach .f 861 to 1525 1 to 665       665/665
(100 %)
1 diff
(99.9 %id)
BF791846 adrenal cortex carcinoma, cell line, adrenal gland .f 863 to 1682 1 to 828       828/1048
(79 %)
30 diff
(97.2 %id)
EC474302 Prostate .f 869 to 962 1 to 94       94/94
(100 %)
0 diff
(100 %id)
AI358085 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .f 875 to 1282 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AA648040 brain .f 888 to 1113 226 to 1       226/226
(100 %)
0 diff
(100 %id)
FN089272 breast carcinoma .f 933 to 1028 96 to 1     Submitted on the opposite strand 96/96
(100 %)
0 diff
(100 %id)
BP290987 lung .f 940 to 1522 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BI334259 cervical carcinoma cell line, cervix .f 944 to 1720 1 to 779       779/786
(99 %)
11 diff
(98.7 %id)
AA312269   .f 986 to 1358 1 to 373       373/373
(100 %)
0 diff
(100 %id)
BF970566 adrenal cortex carcinoma, cell line, adrenal gland .f 1005 to 1793 1 to 789       789/965
(81 %)
17 diff
(98.3 %id)
BG402896 bladder, transitional cell papilloma, cell line .f 1014 to 1853 1 to 838       838/941
(89 %)
22 diff
(97.7 %id)
CN419342 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1028 to 1746 7 to 725       719/725
(99 %)
9 diff
(98.8 %id)
F06035 brain, total brain .f 1056 to 1375 1 to 319       319/319
(100 %)
1 diff
(99.7 %id)
CB154097 Liver .f 1086 to 1741 1 to 656       656/656
(100 %)
0 diff
(100 %id)
BG568468 Liver .f 1107 to 1662 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BX090401 uterus .f 1138 to 1878 1 to 742       742/742
(100 %)
2 diff
(99.8 %id)
CR742798 uterus .f 1138 to 1876 1 to 740       740/740
(100 %)
1 diff
(99.9 %id)
AA156702 uterus .f 1140 to 1582 1 to 443       443/443
(100 %)
0 diff
(100 %id)
BG612368 embryonal carcinoma, testis .f 1153 to 1852 1 to 701       701/701
(100 %)
7 diff
(99.1 %id)
AA808110 brain, substantia nigra .f 1243 to 1435 193 to 1       193/193
(100 %)
0 diff
(100 %id)
AI174963 Liver .f 1310 to 2028 1 to 719       719/719
(100 %)
0 diff
(100 %id)
AV661801 corresponding non cancerous liver tissue .f 1338 to 1850 1 to 516     Submitted on the opposite strand 516/614
(84 %)
2 diff
(99.7 %id)
AV706582 adrenal gland .f 1362 to 2029 1 to 667       667/667
(100 %)
25 diff
(96.3 %id)
AA613891 adrenal adenoma, adrenal gland .f 1400 to 1765 1 to 366     Submitted on the opposite strand 366/366
(100 %)
0 diff
(100 %id)
CB131971 Liver .f 1411 to 1945 1 to 535       535/535
(100 %)
0 diff
(100 %id)
BG563889 Liver .f 1421 to 2119 1 to 700       700/703
(99 %)
7 diff
(99.1 %id)
AV723686 hypothalamus .f 1422 to 2161 20 to 752       733/754
(97 %)
6 diff
(99.3 %id)
CN419336 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 1438 to 2137 1 to 702       702/702
(100 %)
4 diff
(99.5 %id)
BF969967 adrenal cortex carcinoma, cell line, adrenal gland .f 1439 to 2219 1 to 785       785/1096
(71 %)
25 diff
(97.8 %id)
AA169732   .f 1450 to 1919 1 to 470       470/470
(100 %)
0 diff
(100 %id)
CB962718 Blood vessels - aorta, basilar and artery .f 1451 to 2180 1 to 738       738/764
(96 %)
13 diff
(98.3 %id)
CN419331 embryonic stem cells, cell lines H1, H7, andH9 .f 1453 to 1591 1 to 139       139/139
(100 %)
0 diff
(100 %id)
TI_149306381   .f 1453 to 2385 1008 to 93   AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 916/991
(92 %)
30 diff
(97.0 %id)
AV708354 adrenal gland .f 1455 to 2167 1 to 713       713/714
(99 %)
8 diff
(98.9 %id)
AA313886 colon .f 1456 to 1783 1 to 328       328/328
(100 %)
0 diff
(100 %id)
CB265699 adipose .f 1459 to 1937 1 to 479       479/479
(100 %)
0 diff
(100 %id)
TI_149274549   .f 1459 to 2410 1004 to 69       936/1095
(85 %)
0 diff
(100 %id)
CN419349 embryonic stem cells, DMSO-treated H9 cellline .f 1465 to 2163 1 to 701       701/701
(100 %)
7 diff
(99.1 %id)
AV724145 hypothalamus .f 1466 to 2160 1 to 691       691/698
(98 %)
9 diff
(98.8 %id)
AW575115 lymph .f 1487 to 2035 566 to 18   AAA   549/549
(100 %)
0 diff
(100 %id)
BG506629 lung .f 1488 to 2135 1 to 649       649/650
(99 %)
4 diff
(99.4 %id)
CB141674 Liver .f 1497 to 2069 1 to 573       573/573
(100 %)
0 diff
(100 %id)
BG571712 placenta .f 1512 to 2178 1 to 664       664/664
(100 %)
3 diff
(99.6 %id)
CB157044 Liver .f 1513 to 2103 1 to 591       591/591
(100 %)
0 diff
(100 %id)
BM716576 eye, fetal eyes .f 1526 to 1983 1 to 458   fully sequenced, Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 458/458
(100 %)
1 diff
(99.8 %id)
BP292902 lung .f 1529 to 2110 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP293090 lung .f 1529 to 2108 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BM786997 stomach .f 1529 to 2136 1 to 608       608/608
(100 %)
2 diff
(99.7 %id)
TI_149302292   .f 1537 to 2390 929 to 78   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 852/961
(88 %)
11 diff
(98.9 %id)
AU120921 whole embryo, mainly body .f 1543 to 2306 2 to 765   capped   764/764
(100 %)
6 diff
(99.3 %id)
TI_154012387   .f 1549 to 2039 623 to 133   AAA   491/491
(100 %)
0 diff
(100 %id)
BM980514 lung, Primary Lung Cystic Fibrosis EpithelialCells .f 1566 to 2390 839 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 821/821
(100 %)
6 diff
(99.3 %id)
CA436143 lung, Metastatic Chondrosarcoma .f 1570 to 2039 488 to 19   AAA   470/470
(100 %)
0 diff
(100 %id)
CA315032 Human Lung Epithelial cells, lung .f 1584 to 2403 817 to 1       817/817
(100 %)
9 diff
(98.9 %id)
AA314088 colon .f 1587 to 2098 1 to 512       512/512
(100 %)
0 diff
(100 %id)
AW951826   .f 1588 to 2254 1 to 662       662/663
(99 %)
16 diff
(97.6 %id)
T28256 colon, embryo .f 1620 to 1940 1 to 321       321/321
(100 %)
0 diff
(100 %id)
AI282255 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .f 1633 to 2035 429 to 27   AAA   403/403
(100 %)
0 diff
(100 %id)
CB163092 Liver .f 1648 to 2276 1 to 630       630/630
(100 %)
1 diff
(99.9 %id)
AU138208 placenta .f 1648 to 2346 2 to 701   fully sequenced, capped, AAA   700/700
(100 %)
5 diff
(99.3 %id)
BP318847 pericardium .f 1651 to 2233 1 to 583       583/583
(100 %)
0 diff
(100 %id)
TI_154020118   .f 1672 to 2390 797 to 78   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 720/721
(99 %)
6 diff
(99.2 %id)
AI961798 thymus, pooled .f 1675 to 2043 381 to 13   AAA   369/369
(100 %)
0 diff
(100 %id)
BU686428 lung, Primary Lung Epithelial Cells .f 1676 to 2405 727 to 1       727/727
(100 %)
6 diff
(99.2 %id)
AB062486   .f 1695 to 2780 1 to 1086   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 1086/1086
(100 %)
0 diff
(100 %id)
BU676206 lung, Primary Lung Epithelial Cells .f 1711 to 2405 693 to 1       693/693
(100 %)
3 diff
(99.6 %id)
CA438262 lung, Metastatic Chondrosarcoma .f 1712 to 2390 698 to 19   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 680/680
(100 %)
2 diff
(99.8 %id)
AA362943 ovary .f 1723 to 1940 1 to 218       218/218
(100 %)
0 diff
(100 %id)
BE018651 cervix .f 1726 to 2275 1 to 550       550/550
(100 %)
0 diff
(100 %id)
AV727165 hypothalamus .f 1755 to 2390 1 to 635   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 635/635
(100 %)
2 diff
(99.7 %id)
BM697450 eye, fetal eyes .f 1774 to 2187 1 to 414   fully sequenced,   414/414
(100 %)
0 diff
(100 %id)
AI824024 2 pooled tumors (clear cell type), Kidney .f 1782 to 2392 612 to 1       612/612
(100 %)
3 diff
(99.6 %id)
CD722270 eye, lacrimal gland .f 1804 to 2411 1 to 608       608/608
(100 %)
0 diff
(100 %id)
CD299207 Blood vessels - aorta, basilar and artery .f 1826 to 2497 1 to 683       683/715
(95 %)
14 diff
(98.1 %id)
BE550249 carcinoid, lung .f 1837 to 2393 557 to 1       557/557
(100 %)
0 diff
(100 %id)
TI_149287505   .f 1837 to 2780 1005 to 69   AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 937/1146
(81 %)
31 diff
(97.3 %id)
AI801891 carcinoid, lung .f 1849 to 2393 545 to 1       545/545
(100 %)
0 diff
(100 %id)
AW951003   .f 1850 to 2521 1 to 672       672/673
(99 %)
20 diff
(97.1 %id)
BE222276 carcinoid, lung .f 1869 to 2389 521 to 1       521/521
(100 %)
0 diff
(100 %id)
AA150498 uterus .f 1906 to 2390 486 to 1       486/486
(100 %)
1 diff
(99.8 %id)
BU738131 eye, fetal eyes .f 1953 to 2390 457 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 439/439
(100 %)
1 diff
(99.8 %id)
F02283 brain, total brain .f 2123 to 2390 268 to 1       268/273
(98 %)
0 diff
(100 %id)
BU735650 eye, fetal eyes .f 2157 to 2408 252 to 1   fully sequenced,   252/252
(100 %)
2 diff
(99.3 %id)
AU150535   .f 2205 to 2786 582 to 1   tiling clone,   582/582
(100 %)
6 diff
(99.0 %id)
DB377831 placenta .f 2316 to 2796 479 to 1   tiling clone, fully sequenced,   479/479
(100 %)
10 diff
(98.0 %id)
BE302225 cervix .f 2338 to 2780 443 to 1       443/443
(100 %)
0 diff
(100 %id)
DB359780 whole embryo, mainly body .f 2543 to 2796 253 to 1       253/253
(100 %)
3 diff
(98.9 %id)
DB286161 uterus .g 1 to 545 2 to 546   tiling clone, capped   545/545
(100 %)
0 diff
(100 %id)
AK310447 testis .g 25 to 1174 1 to 1150   tiling clone,   1150/1150
(100 %)
0 diff
(100 %id)
DB080181 testis .g 26 to 599 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
AV748141 Pituitary .g 491 to 873 372 to 1     Submitted on the opposite strand 372/372
(100 %)
6 diff
(98.4 %id)
DA862679 placenta .g 523 to 997 2 to 477   capped   476/476
(100 %)
2 diff
(99.6 %id)
DA016777 adrenal gland .g 527 to 1082 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DB139303 thymus .g 552 to 1097 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BX456885 thymus .g 704 to 1618 1 to 909       909/912
(99 %)
17 diff
(98.2 %id)
DA092673 cerebellum .g 719 to 1174 2 to 458   capped   457/457
(100 %)
2 diff
(99.6 %id)
CN419344 embryonic stem cells, DMSO-treated H9 cellline .g 735 to 1145 1 to 411       411/411
(100 %)
1 diff
(99.8 %id)
DB208501 trachea .g 791 to 1269 2 to 480   capped   479/479
(100 %)
1 diff
(99.8 %id)
DR158560 human embryonic stem cells differentiated toan early endodermal cell type .g 816 to 1573 1 to 756       756/756
(100 %)
2 diff
(99.8 %id)
FN074792 breast carcinoma .g 823 to 910 1 to 87       87/96
(90 %)
1 diff
(99.0 %id)
AL832279 lymph node .g 894 to 3926 1 to 3033 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 3033/3033
(100 %)
1 diff
(100.0 %id)
FN151091 breast carcinoma .g 968 to 1063 1 to 97       97/97
(100 %)
1 diff
(99.0 %id)
FN047768 breast carcinoma .g 986 to 1040 55 to 1     Submitted on the opposite strand 55/56
(98 %)
0 diff
(100 %id)
CA389446 eye, RPE/choroid .g 1028 to 1507 1 to 480       480/480
(100 %)
0 diff
(100 %id)
BY797317 eye .g 1079 to 1660 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DA045488 bladder .g 1099 to 1676 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
AU311620 neuroblastoma .g 1155 to 1648 1 to 495       495/495
(100 %)
1 diff
(99.8 %id)
EB387254 eye, optic nerve .g 1158 to 1989 1 to 832       832/832
(100 %)
1 diff
(99.9 %id)
BM997801 lung, Lung Focal Fibrosis .g 1169 to 1807 19 to 658     Submitted on the opposite strand 640/640
(100 %)
3 diff
(99.6 %id)
BP380375 uterus .g 1219 to 1800 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP375311 uterus .g 1339 to 1893 1 to 554       554/554
(100 %)
2 diff
(99.7 %id)
BP368737 thymus .g 1341 to 1922 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
CN419337 embryonic stem cells, DMSO-treated H9 cellline .g 1382 to 2014 1 to 633       633/633
(100 %)
4 diff
(99.4 %id)
BF351361 head_neck .g 1398 to 1758 497 to 135       363/497
(73 %)
6 diff
(98.8 %id)
BE676197 B-cell, chronic lymphotic leukemia .g 1454 to 1992 541 to 5       537/541
(99 %)
2 diff
(99.7 %id)
AW467272 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .g 1487 to 1820 334 to 1       334/334
(100 %)
0 diff
(100 %id)
AI125986 uterus .g 1489 to 1994 507 to 1       507/507
(100 %)
1 diff
(99.9 %id)
CB241000 Human Lung Epithelial cells, lung .g 1490 to 2229 739 to 1       739/743
(99 %)
0 diff
(100 %id)
CN419345 embryonic stem cells, cell lines H1, H7, andH9 .g 1502 to 2208 13 to 720       708/721
(98 %)
8 diff
(98.9 %id)
AW748088 breast .g 1512 to 1912 402 to 2       401/402
(99 %)
9 diff
(97.8 %id)
TI_159713108   .g 1522 to 1994 559 to 87   AAA   473/1028
(46 %)
8 diff
(99.3 %id)
CB851975 Human Lung Epithelial cells, lung .g 1522 to 1994 494 to 22   AAA   473/484
(97 %)
8 diff
(98.4 %id)
BM990861 lung, Lung Focal Fibrosis .g 1559 to 1977 19 to 437     Submitted on the opposite strand 419/427
(98 %)
2 diff
(99.6 %id)
CA434699 lung, Lung Focal Fibrosis .g 1567 to 2002 17 to 452     Submitted on the opposite strand 436/446
(97 %)
5 diff
(98.9 %id)
BU568310 testis .g 1575 to 2199 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
BP223261 colon mucosa .g 1602 to 2296 1 to 702       702/736
(95 %)
15 diff
(98.0 %id)
DB348692 trachea .g 3392 to 3926 536 to 1       536/536
(100 %)
2 diff
(99.7 %id)
BG720849 testis .h -8 to 636 1 to 644   tiling clone,   644/644
(100 %)
5 diff
(99.3 %id)
TI_149277846   .h 508 to 1173 749 to 84   tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 666/667
(99 %)
2 diff
(99.8 %id)
DB260198 uterus .i 1 to 575 2 to 576   tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
DA100719 cerebellum .i 17 to 511 2 to 500   capped   499/499
(100 %)
2 diff
(99.6 %id)
DA504828 brain .i 33 to 606 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BX640645 colon endothel, primary cell culture .i 280 to 4281 1 to 4005 V230Q T231V R232T D233R Y234D ... tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 4005/4005
(100 %)
8 diff
(99.9 %id)
DB284974 uterus .i 285 to 831 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
DA159605 amygdala .i 286 to 855 2 to 570   capped   569/569
(100 %)
4 diff
(99.3 %id)
BM828672 Ascites, stomach .i 312 to 755 1 to 443       443/443
(100 %)
2 diff
(99.6 %id)
DB124704 thymus .i 385 to 920 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA937678 Spleen .i 400 to 964 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA506152 brain .i 463 to 1007 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA558073   .i 463 to 1029 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA309969 hippocampus .i 464 to 1041 2 to 577   capped   576/576
(100 %)
4 diff
(99.4 %id)
DA249680 brain .i 488 to 1060 2 to 574   capped   573/574
(99 %)
1 diff
(99.9 %id)
BX643455   .i 492 to 1078 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
BJ990676 hepatoblastoma .i 574 to 1165 10 to 600       591/600
(98 %)
6 diff
(99.0 %id)
R92851 liver and spleen .i 678 to 1049 1 to 380       380/382
(99 %)
11 diff
(97.2 %id)
DA363708 subthalamic nucleus .i 699 to 1272 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BE162593 head_neck .i 701 to 1186 513 to 23     Submitted on the opposite strand 491/513
(95 %)
0 diff
(100 %id)
CB856448 anterior tongue, pooled .i 702 to 966 35 to 299     Submitted on the opposite strand 265/299
(88 %)
6 diff
(98.0 %id)
CB856449 anterior tongue, pooled .i 702 to 1132 431 to 1   AAA Submitted on the opposite strand 431/465
(92 %)
0 diff
(100 %id)
DA733321   .i 745 to 1437 2 to 694   capped   693/699
(99 %)
6 diff
(99.2 %id)
BM706894 eye, optic nerve .i 755 to 1423 9 to 677       669/677
(98 %)
6 diff
(99.2 %id)
DB245692 uterus, tumor tissue .i 795 to 1361 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB452097 testis .i 836 to 1322 1 to 487       487/487
(100 %)
0 diff
(100 %id)
DA862990 placenta .i 847 to 1396 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DB100760 testis .i 847 to 1419 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
BM750774 Ascites, stomach .i 957 to 1403 1 to 447       447/447
(100 %)
0 diff
(100 %id)
DB152292 thymus .i 963 to 1551 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
BM468945 duodenal adenocarcinoma, cell line, small intestine .i 967 to 1913 1 to 942   tiling clone,   942/942
(100 %)
24 diff
(97.5 %id)
DB146208 thymus .i 967 to 1496 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
DA833841 placenta .i 1024 to 1762 2 to 738   capped   737/768
(95 %)
18 diff
(97.7 %id)
CV570815 cornea, eye .i 1037 to 1649 1 to 613       613/613
(100 %)
0 diff
(100 %id)
DA253613 caudate nucleus .i 1056 to 1634 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
AA581318 bulk alveolar tumor .i 1484 to 1948 1 to 465       465/465
(100 %)
1 diff
(99.8 %id)
BG925883 cartilage .i 1524 to 2105 91 to 672       582/599
(97 %)
11 diff
(98.2 %id)
CN419335 embryonic stem cells, cell lines H1, H7, andH9 .i 1568 to 2248 1 to 682       682/682
(100 %)
3 diff
(99.6 %id)
CN419340 embryonic stem cells, cell lines H1, H7, andH9 .i 1586 to 2274 1 to 691       691/691
(100 %)
4 diff
(99.5 %id)
CV573148 cornea, eye .i 1654 to 2236 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BJ990677 hepatoblastoma .i 1804 to 2343 540 to 1       540/540
(100 %)
0 diff
(100 %id)
AW016473   .i 1815 to 2237 9 to 431     Submitted on the opposite strand 423/431
(98 %)
7 diff
(98.4 %id)
TI_154092971   .i 1817 to 2344 91 to 617     Submitted on the opposite strand 527/1188
(44 %)
9 diff
(99.3 %id)
AA909750 carcinoid, lung .i 1845 to 2269 1 to 425     Submitted on the opposite strand 425/426
(99 %)
8 diff
(98.2 %id)
AI306386 carcinoid, lung .i 1845 to 2276 1 to 432     Submitted on the opposite strand 432/432
(100 %)
0 diff
(100 %id)
CA440587 lung, Lung Focal Fibrosis .i 1846 to 2367 19 to 540     Submitted on the opposite strand 522/522
(100 %)
0 diff
(100 %id)
CN480511 lung, Lung Focal Fibrosis .i 1846 to 2432 19 to 605     Submitted on the opposite strand 587/587
(100 %)
4 diff
(99.4 %id)
H58780 liver and spleen .i 1860 to 2153 1 to 305     Submitted on the opposite strand 305/307
(99 %)
16 diff
(94.8 %id)
DB380798 placenta .i 1870 to 2363 493 to 1       493/508
(97 %)
18 diff
(96.5 %id)
AA031633.
matches multiple genes
uterus .i 1895 to 2358 470 to 3     also hits gene ERP44 468/470
(99 %)
5 diff
(99.0 %id)
DA581964 lung .i 1901 to 2459 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BQ016820 lung, Lung Focal Fibrosis .i 1905 to 2576 690 to 19   AAA   672/672
(100 %)
0 diff
(100 %id)
BX479663   .i 1930 to 2482 1 to 553       553/553
(100 %)
0 diff
(100 %id)
R93067 liver and spleen .i 1989 to 2339 356 to 1       356/379
(93 %)
9 diff
(97.7 %id)
AA581286 bulk alveolar tumor .i 2025 to 2363 341 to 3       339/341
(99 %)
1 diff
(99.8 %id)
DB351599 uterus .i 2042 to 2563 522 to 1       522/522
(100 %)
1 diff
(99.9 %id)
DB365223   .i 3352 to 3897 544 to 1   tiling clone,   544/554
(98 %)
10 diff
(98.2 %id)
DA832425 placenta .j 1 to 661 2 to 664   tiling clone, capped   663/663
(100 %)
7 diff
(99.0 %id)
DB378614 placenta .j 1671 to 2157 485 to 1   tiling clone,   485/492
(98 %)
12 diff
(97.6 %id)
AI187803   .k 1 to 532 522 to 2   tiling clone,   521/560
(93 %)
8 diff
(98.6 %id)
BY995855   .k 23 to 738 10 to 725 exact tiling clone,   716/725
(98 %)
6 diff
(99.2 %id)
AV658548 corresponding non cancerous liver tissue .k 126 to 541 1 to 416     Submitted on the opposite strand 416/416
(100 %)
0 diff
(100 %id)
DA833161 placenta .l 1 to 704 2 to 707   tiling clone, capped   706/706
(100 %)
9 diff
(98.8 %id)
DB379758 placenta .l 1309 to 1787 479 to 1   tiling clone,   479/489
(97 %)
11 diff
(97.8 %id)
AF086515   .m 1 to 537 1 to 537   tiling clone, AAA   537/537
(100 %)
0 diff
(100 %id)
W95185 heart .m 1 to 501 1 to 501       501/502
(99 %)
3 diff
(99.5 %id)
CR740910 heart .m 2 to 514 1 to 512       512/512
(100 %)
4 diff
(99.3 %id)
W94637 heart .m 97 to 540 445 to 1       445/449
(99 %)
1 diff
(99.8 %id)
AI400313 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 97 to 540 444 to 1       444/444
(100 %)
0 diff
(100 %id)
T69897 lung .m 234 to 610 1 to 379   fully sequenced,   379/379
(100 %)
5 diff
(98.7 %id)
AW601843 breast .m 446 to 973 530 to 3 V5C R6* tiling clone,   528/530
(99 %)
2 diff
(99.7 %id)
T70224 lung .m 580 to 887 307 to 1   fully sequenced,   307/307
(100 %)
5 diff
(98.4 %id)
DA378391 thalamus .n 1 to 622 2 to 623 exact tiling clone, capped   622/622
(100 %)
1 diff
(99.9 %id)
AK310666 thymus .o 1 to 1210 1 to 1210 G22R tiling clone,   1210/1210
(100 %)
1 diff
(100.0 %id)
DB145457 thymus .o 2 to 485 2 to 485 G22R capped   484/484
(100 %)
1 diff
(99.8 %id)
CN284453 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .o 373 to 820 1 to 448       448/448
(100 %)
9 diff
(98.0 %id)
DA237723 brain .o 408 to 983 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DB145022 thymus .o 408 to 947 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
DA062559 cerebellum .o 444 to 1007 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DB062870 testis .o 595 to 1143 2 to 552   capped   551/551
(100 %)
3 diff
(99.5 %id)
DA029743   .o 660 to 1232 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
DA223144 brain .o 670 to 1233 2 to 567   tiling clone, capped   566/566
(100 %)
2 diff
(99.7 %id)
DA239572 brain .o 759 to 1173 2 to 416   capped   415/415
(100 %)
0 diff
(100 %id)
Z21142   .o 902 to 1119 218 to 1       218/218
(100 %)
2 diff
(99.1 %id)
FN115877 breast carcinoma .o 1089 to 1168 1 to 80       80/80
(100 %)
2 diff
(97.5 %id)
CN425365 embryonic stem cells, cell lines H1, H7, andH9 .p 1 to 531 1 to 531 exact tiling clone,   531/531
(100 %)
1 diff
(99.9 %id)
AK300147 placenta .q 1 to 938 6 to 943 exact tiling clone,   943/943
(100 %)
1 diff
(99.9 %id)
DC380094 placenta .q 1 to 559 6 to 568 G22W G23R G24W G25W G26W ...     568/568
(100 %)
4 diff
(99.3 %id)
DC363095   .q 1 to 541 4 to 544 exact     544/544
(100 %)
0 diff
(100 %id)
DA157431 amygdala .r 1 to 559 2 to 560 exact tiling clone, capped   559/559
(100 %)
0 diff
(100 %id)
BI551959 brain, hippocampus .r 9 to 681 1 to 697 S2Y N3E T4Q T5L V6L ... tiling clone,   697/726
(96 %)
50 diff
(93.2 %id)
TI_44171672   .r 10 to 681 87 to 782 S2Y N3E T4Q T5L V6L ...     696/971
(71 %)
31 diff
(96.9 %id)
BI552045 brain, hippocampus .r 11 to 679 1 to 669 G20V G21A G22E G23V G24V ... tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 669/669
(100 %)
9 diff
(98.7 %id)
BP352636   .r 14 to 601 1 to 588 exact     588/588
(100 %)
0 diff
(100 %id)
TI_44171849   .r 15 to 679 86 to 750 G20V G21A G22E G23V G24V ... tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 665/750
(88 %)
10 diff
(98.7 %id)
BI552135 brain, hippocampus .r 77 to 609 73 to 607 S2Q N3H T4I T5P V6S ...     533/607
(87 %)
14 diff
(97.7 %id)
TI_44171761   .r 77 to 609 152 to 686 S2Q N3H T4I T5P V6S ...     533/686
(77 %)
13 diff
(98.2 %id)
DA404232 thalamus .s 1 to 555 2 to 557 V117X tiling clone, capped   556/556
(100 %)
4 diff
(99.3 %id)
CN425371 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .s 28 to 656 1 to 628 exact tiling clone,   628/628
(100 %)
3 diff
(99.6 %id)
DB228179 trachea .t 1 to 573 2 to 574   tiling clone, capped   573/573
(100 %)
2 diff
(99.7 %id)
DA460469 tongue, tumor tissue .t 34 to 593 2 to 561 exact capped   560/560
(100 %)
0 diff
(100 %id)
DA314700 hippocampus .t 63 to 625 2 to 564 exact capped   563/563
(100 %)
1 diff
(99.9 %id)
DA530664 brain .t 64 to 673 2 to 611 exact capped   610/610
(100 %)
0 diff
(100 %id)
DA804472 brain .t 64 to 611 2 to 549 exact capped   548/548
(100 %)
1 diff
(99.9 %id)
DA211382 brain .t 65 to 617 2 to 554 exact capped   553/553
(100 %)
1 diff
(99.9 %id)
DA811381 brain .t 65 to 619 2 to 556 exact capped   555/555
(100 %)
0 diff
(100 %id)
DB064937 testis .t 65 to 608 2 to 545 exact capped   544/544
(100 %)
1 diff
(99.9 %id)
DB223237 trachea .t 65 to 636 2 to 574 exact capped   573/573
(100 %)
2 diff
(99.7 %id)
DA500557 brain .t 66 to 644 2 to 581 S46L E47* capped   580/580
(100 %)
2 diff
(99.7 %id)
DA189986 amygdala .t 89 to 667 2 to 580 exact capped   579/579
(100 %)
0 diff
(100 %id)
CN425378 embryonic stem cells, cell lines H1, H7, andH9 .t 97 to 787 1 to 692 exact tiling clone,   692/692
(100 %)
5 diff
(99.3 %id)
BQ678861 melanotic melanoma, cell line, skin .u 1 to 647 3 to 651 exact tiling clone,   651/1020
(63 %)
8 diff
(99.3 %id)
DA413006 thalamus .u 24 to 580 2 to 558 exact capped   557/557
(100 %)
0 diff
(100 %id)
W93733 heart .u 30 to 438 1 to 407   fully sequenced,   407/407
(100 %)
9 diff
(97.8 %id)
AW241752 pooled .u 107 to 886 783 to 1 S2N T4S T5P V6F S16H ...     783/783
(100 %)
22 diff
(97.2 %id)
AI671117 pooled germ cell tumors .u 114 to 831 715 to 1       715/716
(99 %)
13 diff
(98.2 %id)
BF439638 pooled .u 158 to 832 674 to 3       672/674
(99 %)
10 diff
(98.6 %id)
BI757145 brain .u 261 to 1046 1 to 782   tiling clone,   782/782
(100 %)
11 diff
(98.6 %id)
TI_57219696   .u 261 to 831 67 to 645       579/733
(78 %)
15 diff
(98.0 %id)
TI_57219925   .u 261 to 1046 66 to 847       782/847
(92 %)
17 diff
(98.0 %id)
AI458259 pooled .u 275 to 830 555 to 1       555/555
(100 %)
3 diff
(99.5 %id)
AA479863 ovarian tumor, ovary .u 276 to 652 1 to 377       377/377
(100 %)
0 diff
(100 %id)
W93734 heart .u 417 to 829 432 to 11   fully sequenced, AAA   422/422
(100 %)
14 diff
(96.7 %id)
DB156307 thymus .u 611 to 1173 2 to 564   capped   563/564
(99 %)
1 diff
(99.9 %id)
DA320091 hippocampus .u 665 to 1220 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB019890 testis .u 733 to 1283 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA401460 thalamus .u 744 to 1293 2 to 551   capped   550/552
(99 %)
1 diff
(99.9 %id)
CD300365 testis .u 817 to 1568 1 to 763       763/889
(85 %)
13 diff
(98.6 %id)
BX506717 Liver .u 828 to 1519 1 to 690   tiling clone,   690/694
(99 %)
4 diff
(99.5 %id)
DB212486 trachea .u 828 to 1284 2 to 461   capped   460/460
(100 %)
3 diff
(99.4 %id)
DB227752 trachea .u 905 to 1466 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
EL595075 epidermis, skin .u 912 to 1218 326 to 18     Submitted on the opposite strand 309/326
(94 %)
0 diff
(100 %id)
CD653772 Embryonic Stem cells .u 1403 to 2242 12 to 844   tiling clone,   833/849
(98 %)
17 diff
(98.0 %id)
DB090091 testis .u 1483 to 2007 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
DB161784 thymus .u 1487 to 2065 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA489713 brain .u 1565 to 2137 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA021456   .u 1588 to 2159 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
AL700085 human skeletal muscle .u 1628 to 2337 1 to 710       710/715
(99 %)
1 diff
(99.9 %id)
DA092173 cerebellum .u 1673 to 2192 2 to 521   capped   520/520
(100 %)
0 diff
(100 %id)
CA397346 eye, RPE/choroid .u 1716 to 2313 1 to 598       598/598
(100 %)
0 diff
(100 %id)
DA144992 amygdala .u 1736 to 2295 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA077902 cerebellum .u 1773 to 2342 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DA961776 Spleen .u 1785 to 2308 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
DA520008 brain .u 1790 to 2364 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
CD653534 Embryonic Stem cells .u 1817 to 2489 6 to 678   tiling clone,   673/772
(87 %)
18 diff
(97.7 %id)
DB088394 testis .u 1819 to 2316 2 to 499   capped   498/498
(100 %)
0 diff
(100 %id)
DB135346 thymus .u 1819 to 2279 2 to 462   capped   461/461
(100 %)
0 diff
(100 %id)
DA020148   .u 1837 to 2397 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB099303 testis .u 2040 to 2620 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
DB197618 trachea .u 2089 to 2687 2 to 601   capped   600/600
(100 %)
2 diff
(99.7 %id)
DA322474 hippocampus .u 2141 to 2698 2 to 558   capped   557/557
(100 %)
3 diff
(99.5 %id)
DA504488 brain .u 2142 to 2715 2 to 578   tiling clone, capped   577/577
(100 %)
4 diff
(99.4 %id)
CN425374 embryonic stem cells, DMSO-treated H9 cellline .va 1 to 347 1 to 347 V22D E44Q A60S tiling clone,   347/347
(100 %)
4 diff
(98.9 %id)
BP221979   .vb 1 to 582 1 to 581 exact tiling clone,   581/581
(100 %)
1 diff
(99.9 %id)
BF849910 lung_normal .vc 1 to 415 1 to 415   tiling clone,   415/415
(100 %)
3 diff
(99.3 %id)
BX496394 Liver .vc 131 to 592 1 to 465       465/465
(100 %)
4 diff
(99.2 %id)
BX646807 Liver .vc 278 to 611 1 to 338     Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 338/338
(100 %)
5 diff
(98.6 %id)
BX537679 fetal brain .vc 328 to 3830 1 to 3505 R16G Q45V V46T T47Q R48D ... tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 3505/3505
(100 %)
10 diff
(99.8 %id)
BX478497   .vc 328 to 949 1 to 622       622/622
(100 %)
0 diff
(100 %id)
CD644487 Embryonic Stem cells .vc 637 to 1428 1 to 782       782/839
(93 %)
20 diff
(97.7 %id)
AW589928 pooled germ cell tumors .vc 677 to 925 451 to 203   AAA   249/427
(58 %)
0 diff
(100 %id)
CN412622 embryonic stem cells, cell lines H1, H7, andH9 .vc 1043 to 1665 1 to 623       623/623
(100 %)
1 diff
(99.9 %id)
DA654430   .vc 1191 to 1739 2 to 550   tiling clone, capped   549/549
(100 %)
1 diff
(99.9 %id)
BX646808 Liver .vc 3356 to 3830 493 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) 475/475
(100 %)
0 diff
(100 %id)
DA678191   .vd-u 1 to 586 2 to 587 exact tiling clone, capped   586/586
(100 %)
0 diff
(100 %id)
BP321890 Pancreas .vd-u 38 to 621 1 to 584 exact     584/584
(100 %)
2 diff
(99.7 %id)
DA939379 Spleen .vd-u 38 to 613 2 to 577 exact capped   576/576
(100 %)
2 diff
(99.7 %id)
DA104846 cerebellum .vd-u 40 to 541 2 to 506 R46L E47R P48T E49L Q50S ... capped   505/505
(100 %)
3 diff
(99.5 %id)
DA321741 hippocampus .vd-u 40 to 541 2 to 503 exact capped   502/502
(100 %)
0 diff
(100 %id)
AA453935   .vd-u 46 to 434 18 to 407       390/407
(95 %)
7 diff
(98.3 %id)
CD643366 Embryonic Stem cells .vd-u 294 to 1079 1 to 782       782/822
(95 %)
8 diff
(99.1 %id)
CN413619 embryonic stem cells, cell lines H1, H7, andH9 .vd-u 343 to 806 1 to 463   tiling clone,   463/463
(100 %)
2 diff
(99.6 %id)
T84663 liver and spleen .vd-u 356 to 750 1 to 410       410/470
(87 %)
19 diff
(96.0 %id)
BX093942 liver and spleen .vd-u 358 to 798 1 to 440       440/440
(100 %)
1 diff
(99.8 %id)
EB386755 eye, optic nerve .vd-u 550 to 1341 1 to 793   tiling clone,   793/793
(100 %)
1 diff
(99.9 %id)
AW452421   .vd-u 961 to 1407 464 to 18   AAA   447/447
(100 %)
2 diff
(99.6 %id)
AI357349 brain, glioblastoma (pooled) .vd-u 963 to 1407 449 to 5       445/449
(99 %)
0 diff
(100 %id)
R10711 liver and spleen .vd-u 983 to 1128 147 to 1       147/147
(100 %)
1 diff
(99.4 %id)
AI423484 brain, glioblastoma (pooled) .vd-u 992 to 1398 416 to 10       407/416
(97 %)
0 diff
(100 %id)
AA453430   .vd-u 1027 to 1400 387 to 14   AAA   374/374
(100 %)
0 diff
(100 %id)
CN268593 embryonic stem cells, cell lines H1, H7, andH9 .vd-u 1178 to 1867 1 to 690   tiling clone,   690/690
(100 %)
3 diff
(99.6 %id)
BP418680 small intestine .vd-u 1224 to 1740 13 to 529     Submitted on the opposite strand 517/529
(97 %)
6 diff
(98.9 %id)
CN268594 embryonic stem cells, cell lines H1, H7, andH9 .vd-u 1325 to 1883 1 to 557   tiling clone,   557/557
(100 %)
4 diff
(99.3 %id)
CN268595 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vd-u 1832 to 2438 13 to 619   tiling clone,   607/619
(98 %)
6 diff
(99.1 %id)
AI168187 pooled .vd-u 1916 to 2360 445 to 1       445/447
(99 %)
1 diff
(99.8 %id)
BX106202 parathyroid gland, parathyroid tumor .vd-u 1922 to 2361 1 to 440   AAA   440/440
(100 %)
0 diff
(100 %id)
AA843168 parathyroid gland, parathyroid tumor .vd-u 1952 to 2354 403 to 1       403/403
(100 %)
0 diff
(100 %id)
AI769176 pooled .vd-u 1952 to 2360 410 to 1       410/410
(100 %)
3 diff
(99.3 %id)
AI184865 pooled .vd-u 1960 to 2360 401 to 1       401/401
(100 %)
0 diff
(100 %id)
AI864115 pooled .vd-u 2115 to 2360 246 to 1       246/246
(100 %)
0 diff
(100 %id)
CR736067 germinal center B cell .vd-u 2330 to 3045 1 to 716   tiling clone,   716/716
(100 %)
1 diff
(99.9 %id)
AW969099   .vd-u 2331 to 2768 1 to 438       438/438
(100 %)
1 diff
(99.8 %id)
BY799363 eye .vd-u 2351 to 2988 1 to 636       636/636
(100 %)
3 diff
(99.6 %id)
BI035609 nervous_normal .vd-u 2503 to 3052 549 to 1       549/549
(100 %)
7 diff
(98.8 %id)
CN285520 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .vd-u 2819 to 3448 1 to 631   tiling clone,   631/633
(99 %)
7 diff
(98.9 %id)
DA571454 whole embryo, mainly head .vd-u 3108 to 3841 2 to 731   tiling clone, capped   730/730
(100 %)
9 diff
(98.8 %id)
DA317646 hippocampus .vd-u 3696 to 4241 2 to 547   tiling clone, capped   546/546
(100 %)
1 diff
(99.9 %id)
BE709693 head_neck .vd-u 4009 to 4327 83 to 401       319/408
(78 %)
4 diff
(99.1 %id)
AA829157 ovary .vd-u 4015 to 4103 1 to 89       89/149
(59 %)
1 diff
(99.4 %id)
CA775581 Pancreas, Purified pancreatic islet .vd-u 4170 to 4604 1 to 435   tiling clone,   435/435
(100 %)
1 diff
(99.8 %id)
DB358310 whole embryo, mainly head .vd-u 4186 to 4751 562 to 1       562/572
(98 %)
23 diff
(96.0 %id)
BM989060 Bone, Subchondral Bone .vd-u 4234 to 4773 558 to 19   tiling clone, AAA   540/540
(100 %)
4 diff
(99.3 %id)
AI299889 carcinoid, lung .vd-u 4325 to 4750 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AA504619 germinal center B cell .vd-u 4332 to 4699 368 to 1       368/368
(100 %)
0 diff
(100 %id)
AA910236 Kidney .vd-u 4348 to 4751 404 to 1       404/404
(100 %)
0 diff
(100 %id)
AA452912   .vd-u 4392 to 4754 363 to 1   tiling clone,   363/363
(100 %)
0 diff
(100 %id)
BX491351   .vd-u 4553 to 5137 1 to 587   tiling clone,   587/587
(100 %)
8 diff
(98.7 %id)
CN293711 embryonic stem cells, DMSO-treated H9 cellline .vd-u 4813 to 5381 9 to 579   tiling clone,   571/579
(98 %)
6 diff
(99.0 %id)
DB200222 trachea .vd-u 5121 to 5695 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BX954410   .vd-u 5240 to 5691 1 to 452   tiling clone,   452/452
(100 %)
3 diff
(99.4 %id)
AW576760 breast_normal .vd-u 5346 to 5922 577 to 2       576/577
(99 %)
0 diff
(100 %id)
BI021390 marrow .vd-u 5466 to 6038 581 to 8       574/581
(98 %)
0 diff
(100 %id)
AK021742 whole embryo, mainly head .vd-u 5567 to 7558 1 to 1992   tiling clone, available from FLJ,   1992/1992
(100 %)
0 diff
(100 %id)
AU118996 whole embryo, mainly head .vd-u 5568 to 6353 2 to 787   capped   786/786
(100 %)
0 diff
(100 %id)
AW139364   .vd-u 5708 to 6109 1 to 402     Submitted on the opposite strand 402/402
(100 %)
3 diff
(99.3 %id)
BG150426 carcinoid, lung .vd-u 5709 to 6058 16 to 365     Submitted on the opposite strand 350/365
(95 %)
6 diff
(98.4 %id)
AI299104 carcinoid, lung .vd-u 5725 to 6155 1 to 431     Submitted on the opposite strand 431/431
(100 %)
1 diff
(99.8 %id)
AI300481 carcinoid, lung .vd-u 5725 to 6380 1 to 656     Submitted on the opposite strand 656/656
(100 %)
1 diff
(99.9 %id)
BQ954560 sciatic nerve .vd-u 5780 to 6686 1 to 909       909/909
(100 %)
8 diff
(99.2 %id)
AL712488 human skeletal muscle .vd-u 5813 to 6430 1 to 620       620/620
(100 %)
3 diff
(99.6 %id)
AL699143 human skeletal muscle .vd-u 5873 to 6456 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BX492562   .vd-u 5943 to 6504 1 to 560       560/560
(100 %)
4 diff
(99.3 %id)
BX110302 carcinoid, lung .vd-u 5949 to 6424 482 to 7     Submitted on the opposite strand 476/482
(98 %)
0 diff
(100 %id)
BE831090 marrow .vd-u 6035 to 6476 465 to 20       446/506
(88 %)
0 diff
(100 %id)
BX951495   .vd-u 6246 to 6932 1 to 687       687/692
(99 %)
3 diff
(99.6 %id)
R81755 placenta .vd-u 6509 to 6939 1 to 440       440/440
(100 %)
16 diff
(96.4 %id)
EH355958   .vd-u 6557 to 6638 1 to 80       80/81
(98 %)
4 diff
(95.1 %id)
CN360086 embryonic stem cells, cell lines H1, H7, andH9 .vd-u 6683 to 7240 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
CN360088 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vd-u 6741 to 7083 1 to 343       343/343
(100 %)
1 diff
(99.8 %id)
GD137218   .vd-u 6893 to 7010 117 to 1     Submitted on the opposite strand 117/118
(99 %)
3 diff
(97.5 %id)
AU145435 whole embryo, mainly head .vd-u 6972 to 7558 576 to 1       576/576
(100 %)
17 diff
(97.1 %id)
DB308889 hippocampus .vd-u 6987 to 7551 565 to 1       565/565
(100 %)
1 diff
(99.9 %id)
R81509 placenta .vd-u 7194 to 7535 347 to 1       347/347
(100 %)
16 diff
(95.4 %id)
AK311184 brain .ve 1 to 842 5 to 847   tiling clone,   847/847
(100 %)
1 diff
(99.9 %id)
DA219168 brain .ve 1 to 566 5 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
AI027393 parathyroid gland, parathyroid tumor .ve 52 to 573 534 to 14   AAA   521/544
(95 %)
5 diff
(99.1 %id)
AI685496 Prostate .ve 55 to 818 767 to 1       767/767
(100 %)
5 diff
(99.4 %id)
AI214270 pooled germ cell tumors .ve 67 to 575 506 to 1       506/506
(100 %)
3 diff
(99.5 %id)
CN360085 embryonic stem cells, cell lines H1, H7, andH9 .ve 70 to 567 27 to 524       498/524
(95 %)
6 diff
(98.9 %id)
AA905183 pooled .ve 90 to 633 544 to 1       544/546
(99 %)
6 diff
(99.0 %id)
AI332345 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .ve 97 to 630 534 to 1       534/534
(100 %)
0 diff
(100 %id)
AA683543 heart .ve 100 to 629 530 to 1       530/530
(100 %)
0 diff
(100 %id)
AW390940 stomach .ve 104 to 575 483 to 12       472/491
(96 %)
0 diff
(100 %id)
CV341581 head_neck .ve 126 to 589 1 to 474       474/487
(97 %)
40 diff
(91.8 %id)
BP418889 small intestine .ve 127 to 635 1 to 509     Submitted on the opposite strand 509/509
(100 %)
1 diff
(99.9 %id)
AW390938 stomach .ve 144 to 585 449 to 8       442/449
(98 %)
0 diff
(100 %id)
AW978715   .ve 152 to 629 479 to 1     Submitted on the opposite strand 479/489
(97 %)
4 diff
(99.2 %id)
DB548175 hippocampus .ve 157 to 630 1 to 474     Submitted on the opposite strand 474/474
(100 %)
1 diff
(99.8 %id)
FN167124 breast carcinoma .ve 193 to 276 82 to 1     Submitted on the opposite strand 82/89
(92 %)
2 diff
(97.8 %id)
AA831969 germinal center B cell .ve 204 to 639 436 to 1       436/436
(100 %)
0 diff
(100 %id)
DB232634 trachea .ve 206 to 751 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
AI202900 pooled germ cell tumors .ve 247 to 575 329 to 1       329/329
(100 %)
0 diff
(100 %id)
CN360087 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .ve 256 to 804 1 to 550       550/550
(100 %)
3 diff
(99.5 %id)
BX495577 Liver .ve 332 to 852 11 to 531   tiling clone,   521/531
(98 %)
6 diff
(98.9 %id)
AA829323 germinal center B cell .ve 336 to 639 304 to 1       304/304
(100 %)
1 diff
(99.7 %id)
DB212929 trachea .ve 393 to 818 2 to 426   capped   425/425
(100 %)
2 diff
(99.6 %id)
AI914832 ovary, tumor, 5 pooled (see description) .ve 465 to 631 167 to 1       167/167
(100 %)
0 diff
(100 %id)
GD144358   .ve 554 to 630 1 to 77   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 77/77
(100 %)
1 diff
(98.8 %id)
DA248615 brain .ve 749 to 1334 2 to 587   tiling clone, capped   586/586
(100 %)
1 diff
(99.9 %id)
BG621724 placenta .ve 769 to 1484 1 to 724   tiling clone,   724/727
(99 %)
16 diff
(97.8 %id)
BX456552 thymus .vf 1 to 937 1 to 931 N3X S45T S46L E47S Q48R ... tiling clone,   931/935
(99 %)
15 diff
(98.4 %id)
CN425373 embryonic stem cells, cell lines H1, H7, andH9 .vf 33 to 698 1 to 665 exact     665/665
(100 %)
3 diff
(99.6 %id)
AK301670 esophagus, tumor tissue .vf 59 to 1074 1 to 1016 exact tiling clone,   1016/1016
(100 %)
1 diff
(100.0 %id)
DC394191 esophageal, tumor tissue .vf 59 to 627 1 to 569 exact     569/569
(100 %)
1 diff
(99.9 %id)
BM264623 Pancreas, Purified pancreatic islet .vf 492 to 1072 581 to 1   tiling clone,   581/581
(100 %)
0 diff
(100 %id)
CF594313 Human Placenta, placenta .vg -8 to 787 29 to 839 exact tiling clone,   811/844
(96 %)
23 diff
(97.3 %id)
BX956191   .vh-u 1 to 475 1 to 473 exact tiling clone,   473/473
(100 %)
1 diff
(99.8 %id)
DA176524 amygdala .vh-u 302 to 764 2 to 464   tiling clone, capped   463/463
(100 %)
2 diff
(99.6 %id)
TI_149282720   .vi 1 to 583 678 to 95 R3K R4E R5E T6D P7S ... tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 584/670
(87 %)
11 diff
(98.4 %id)
AL704211 human skeletal muscle .vj-u 1 to 445 1 to 445 exact tiling clone,   445/445
(100 %)
0 diff
(100 %id)
TI_153987999   .vj-u 139 to 578 506 to 69   tiling clone,   438/506
(86 %)
0 diff
(100 %id)
AW204315   .vj-u 159 to 558 413 to 16   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 398/398
(100 %)
1 diff
(99.8 %id)
DB254402 uterus .vk 1 to 551 5 to 555   tiling clone, capped   554/554
(100 %)
3 diff
(99.5 %id)
DB145852 thymus .vk 33 to 573 2 to 542 exact tiling clone, capped   541/541
(100 %)
13 diff
(97.6 %id)
DB123909 thymus .vl 1 to 556 2 to 557 exact tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DA318801 hippocampus .vm 1 to 415 2 to 416 exact tiling clone, capped   415/415
(100 %)
0 diff
(100 %id)
BU659218 blood .vn 1 to 408 1 to 408 exact tiling clone,   408/408
(100 %)
0 diff
(100 %id)
DW413409 Liver .vo 1 to 302 19 to 320 exact tiling clone,   306/320
(95 %)
7 diff
(97.9 %id)
DW436752 Liver .vo 27 to 232 46 to 251       206/251
(82 %)
6 diff
(97.7 %id)
258 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd-u, .ve, .vf, .vg, .vh-u, .vi, .vj-u, .vk, .vl, .vm, .vn, .vo Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI